Ara
Toplam kayıt 44, listelenen: 41-44
Is adalimumab protective in ischemia‐reperfusion injury in lung?
(Mashhad University of Medical Sciences, 2015)
Objective(s): Increasing cytokines and reactive oxygen species (ROS) during ischemia reperfusion (I?R) leads to the lung damage. Adalimumab (Ada) is a potent tumor necrosis factor?alpha (TNF??) inhibitor agent. We aimed ...
Somatostatin receptor 2 and 5 expressions in gastroenteropancreatic neuroendocrine tumors in Turkey
(Asian Pacific Organization for Cancer Prevention, 2015)
Background: Gastroenteropancreatic neuroendocrine tumors (GNs) are slow growing and although their incidence has increased in recent years, they are relatively rarely seen. Somatostatin analogues are used in the treatment ...
Relationships between C-kit expression and mean platelet volume in benign, preneoplastic and neoplastic endometrium
(Asian Pacific Organization for Cancer Prevention, 2015)
Background: c-Kit is a proto-oncogene that encodes a tyrosine kinase receptor (CD117). Mean platelet volume (MPV) is a useful marker for demonstrating thrombocyte function. We aimed to investigate whether c-kit is expressed ...
Topiramate reduces aortic cross-clamping-induced lung injury in male rats
(NLM (Medline), 2018)
BACKGROUND: Topiramate (TPM) decreases cytokine release and generation of reactive oxygen species (ROS). Cytokine and endothelin-1 (ET-1) secretion and ROS formation play an important role in ischemia-reperfusion (I/R) ...